Lipid abnormalities in patients with adrenal incidentalomas: Role of subclinical hypercortisolism and impaired glucose metabolism

Journal of Endocrinological Investigation

Volumn 38, Issue 6, 2015, Pages 623-628

  Masserini, B ^a   Morelli, V ^a   Palmieri, S ^a   Eller Vainicher, C ^a   Zhukouskaya, V ^a   Cairoli, E ^a   Orsi, E ^a   Beck Peccoz, P ^a   Spada, A ^a   Chiodini, I ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adrenal incidentaloma; Diabetes mellitus; Dyslipidemia; Glucose metabolism; Lipid pattern; Subclinical hypercortisolism

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

ADRENAL INCIDENTALOMA; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERCORTISOLISM; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; ADRENAL GLAND NEOPLASMS; AGED; BLOOD; COMORBIDITY; CUSHING SYNDROME; DYSLIPIDEMIAS; GLUCOSE INTOLERANCE; MIDDLE AGED; PATHOLOGY;

ADRENAL GLAND NEOPLASMS; AGED; COMORBIDITY; CUSHING SYNDROME; DYSLIPIDEMIAS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PREVALENCE;

EID: 84929173591     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0232-0     Document Type: Article

References (26)

1. Ross NS, Aron DC (1990) Hormonal evaluation of the patient with an incidentally discovered adrenal mass. NEJM 323(20):1401-1405
2. Kloos RT, Gros MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460-484
3. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149(4):273-285
4. Singh PK, Buch HN (2008) Adrenal incidentaloma: evaluation and management. J Clin Pathol 61(11):1168-1173. doi: 10.1136/jcp.2006.044313
5. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85(2):637-644
6. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W (2002) Preclinical Cushing's syndrome in adrenal incidentalomas: comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75(3):826-832
7. Tsagarakis S, Vassiliadi D, Thalassinos N (2006) Endogenous Subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest 29(5):471-482
8. Chiodini I, Guglielmi G, Battista C, Carnevale V, Torlontano M, Cammisa M, Trischitta V, Scillitani A (2004) Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status. J Clin Endocrinol Metab 89(5):2237-2241
9. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A (2007) Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147(8):541-548
10. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V (2005) Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 153(6):837-844
11. Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. J Clin Endocrinol Metab 94(9):3207-3214. doi: 10.1210/jc.2009-0468
12. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87(3):998-1003
13. Fernández-Real JM, Engel WR, Simó R, Salinas I, Webb SM (1998) Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Clin Endocrinol 49(1):53-61
14. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87(11):4872-4878
15. Chiodini I (2011) Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96(5):1223-1236. doi: 10.1210/jc.2010-2722
16. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85(4):1440-1448
17. Ginsberg HN (2006) Efficacy and mechanism of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 91(2):383-392
18. Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M (2010) Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology 92(Suppl 1):86-90. doi: 10.1159/000314213
19. van Raalte DH, Ouwens DM, Diamant M (2009) Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 39(2):81-93. doi: 10.1111/j.1365-2362.2008.02067.x
20. Mullugeta Yonas, Chawla Rajinder, Kebede Tedla, Worku Yesehak (2012) Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian J Clin Biochem 27(4):363-369
21. Gatti A, Maranghi M, Bacci S, Carallo C, Gnasso A, Mandosi E, Fallarino M, Morano S, Trischitta V, Filetti S (2009) Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes. Diabetes Care 32(8):1550-1552. doi: 10.2337/dc09-0256
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285(19):2486-2497
23. American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1):S62-S67. doi: 10.2337/dc09-S062
24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension (2007) 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25(9):1751-1762
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-441
26. Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M, Ambrosi B, Scillitani A, Ghigo E, Beck-Peccoz P, Terzolo M, Chiodini I (2014) Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. J Clin Endocrinol Metab 99(3):827-834